AdvaMed CEO Scott Whitaker says he is open to any and all possible legislative vehicles to pass a permanent repeal of the 2.3% device excise tax.
"We are not saying one vehicle only to get device tax repeal done; we're saying whatever it takes to get it done," Whitaker said during a recent call with journalists. "If there's a pathway on MDUFA, we'd be open to that, if there's a pathway on SCHIP we'd be open to that, and if there's a pathway on tax reform we'd be open to that as well
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?